|
Volumn 3 Suppl 1, Issue , 1996, Pages
|
Technology assessment in Canada: comparison of magnetic field strength in the assessment of complex partial seizures.
a a a a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ARTICLE;
BIOMEDICAL TECHNOLOGY ASSESSMENT;
CANADA;
CLINICAL TRIAL;
COMPARATIVE STUDY;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
COST BENEFIT ANALYSIS;
COST CONTROL;
ECONOMICS;
HUMAN;
INSTRUMENTATION;
NUCLEAR MAGNETIC RESONANCE IMAGING;
PATHOLOGY;
RANDOMIZED CONTROLLED TRIAL;
SENSITIVITY AND SPECIFICITY;
TEMPORAL LOBE;
TEMPORAL LOBE EPILEPSY;
COST SAVINGS;
COST-BENEFIT ANALYSIS;
EPILEPSY, TEMPORAL LOBE;
HUMANS;
MAGNETIC RESONANCE IMAGING;
ONTARIO;
SENSITIVITY AND SPECIFICITY;
TECHNOLOGY ASSESSMENT, BIOMEDICAL;
TEMPORAL LOBE;
MLCS;
MLOWN;
|
EID: 0030119763
PISSN: 10766332
EISSN: None
Source Type: Journal
DOI: 10.1016/s1076-6332(96)80486-7 Document Type: Article |
Times cited : (1)
|
References (0)
|